| Completed | Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD) GVHD, Adult Acute Myeloid Leukemia, Adult Acute Lymphoid Leukemia | Phase 3 | 2011-10-10 |
| Terminated | A Open Label, Dose Escalating Study to Evaluate the Safety and Tolerability of Ascending Intravenous (i.v.) Do Epithelial Cancer Patients | Phase 1 | 2011-02-01 |
| Completed | Safety Study of Second Intraperitoneal (I.P.) Infusion Cycle of Catumaxomab in Patients With Malignant Ascites Malignant Ascites Due to Epithelial Carcinoma | Phase 2 | 2009-11-01 |
| Completed | CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Cancer, Neoplasms, Carcinoma | Phase 3 | 2008-12-01 |
| Terminated | Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression Metastatic Breast Cancer, Advanced Breast Cancer | Phase 2 | 2008-01-01 |
| Completed | Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients W Ovarian Cancer, Epithelial Ovarian Cancer | Phase 2 | 2007-11-01 |
| Completed | Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection Gastric Cancer, Gastric Adenocarcinoma | Phase 2 | 2007-04-01 |
| Terminated | Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Metastatic Breast Cancer, Advanced Breast Cancer | Phase 2 | 2007-03-01 |
| Terminated | Efficacy and Safety of ATG-Fresenius Following a Renal Transplantation, Without Corticosteroids Renal Transplant Rejection | Phase 3 | 2006-10-01 |
| Completed | Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy Ovarian Cancer | Phase 2 | 2006-09-01 |
| Completed | Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma Gastric Cancer, Gastric Adenocarcinoma | Phase 2 | 2006-07-01 |
| Terminated | Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metasta Breast Neoplasms, Breast Cancer | Phase 2 | 2006-07-01 |
| Completed | Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites Malignant Ascites | Phase 2 | 2006-06-01 |
| Completed | EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection Chronic Obstructive Pulmonary, Idiopathic Pulmonary Fibrosis, Cystic Fibrosis | Phase 3 | 2005-01-01 |
| Completed | Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast), Malignant Ascites | Phase 2 / Phase 3 | 2004-09-01 |
| Completed | Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Tr Graft vs Host Disease | Phase 3 | 2003-02-01 |